All In Biotech

NDA 020161 · Otsuka Icu Medcl

Potassium Chloride 20meq In Plastic Container

Potassium Chloride · Injection

Last checked: Nov 19, 2026Latest source record: Nov 1, 2002 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1992

Nov 30, 1992

Approved uses

1

Original approval plus efficacy supplements

Registered trials

9,299

2,122 Phase 3, 968 recruiting

FAERS reports

93,810

69,872 serious, 13,688 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

Boxed warning

Highly Concentrated

What it is approved for

From the label in effect Oct 29, 2025.

INDICATIONS AND USAGE Potassium Chloride Injection is indicated in the treatment of potassium deficiency states when oral replacement is not feasible. THIS HIGHLY CONCENTRATED, READY-TO-USE POTASSIUM CHLORIDE INJECTION IS INTENDED FOR THE MAINTENANCE OF SERUM K + LEVELS AND FOR POTASSIUM SUPPLEMENTATION IN FLUID RESTRICTED PATIENTS WHO CANNOT ACCOMMODATE ADDITIONAL VOLUMES OF FLUID ASSOCIATED WITH POTASSIUM SOLUTIONS OF LOWER CONCENTRATION. When using these products, these patients should be on continuous cardiac monitoring and frequent testing for serum potassium concentration and acid-base balance.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Nov 30, 1992 Original approval · Type 3 - New Dosage Form
6 products under this application
  • POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 29.8MG/ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 2.98GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 1.49GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 14.9MG/ML · INJECTABLE, INJECTION · Prescription · TE AP
  • POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 2.24GM/100ML · INJECTABLE, INJECTION · Discontinued
  • POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER · POTASSIUM CHLORIDE 745MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP

Clinical trials

Interventional ClinicalTrials.gov studies with "Chloride" as an intervention, any sponsor and status, largest first.

All 9,299 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • diarrhoea6,883
  • dyspnoea6,837
  • nausea6,626
  • fatigue6,413
  • death4,665
  • pneumonia4,544
  • headache4,281
  • vomiting4,214
  • asthenia4,206
  • off label use4,119
  • dizziness4,050
  • pain3,918

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004901
20051,824
20061,348
20071,683
20082,435
20092,665
20102,185
20112,586
20123,567
20132,072
20142,479
20153,923
20164,697
20174,797
20185,789
20195,658
20205,668
20216,017
20226,667
20236,693
20247,494
20257,576
20265,080

Recalls

4 FDA enforcement reports for this application.

  • Oct 29, 2025 · Class I · Ongoing

    Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq

  • Oct 29, 2025 · Class I · Ongoing

    Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq

  • Feb 13, 2025 · Class I · Ongoing

    Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq

  • Feb 13, 2025 · Class I · Ongoing

    Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling...

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 4,091 on PubMed

Sponsor: Otsuka · Also marketed as Potassium Chloride 40meq In Plastic Container, Potassium Chloride 10meq In Plastic Container, Potassium Chloride 30meq In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.